Expression of the neural cell adhesion molecule CD56 is associated with short remission duration and survival in acute myeloid leukemia with t(8;21) (q22;q22)

Blood

Volumn 90, Issue 4, 1997, Pages 1643-1648

  Baer, Maria R ^a   Stewart, Carleton C ^b   Lawrence, David ^b   Arthur, Diane C ^b   Byrd, John C ^b   Davey, Frederick R ^b   Schiffer, Charles A ^b   Bloomfield, Clara D ^b  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD56 ANTIGEN; CYTARABINE; DAUNORUBICIN; NERVE CELL ADHESION MOLECULE;

ACUTE GRANULOCYTIC LEUKEMIA; ANTIGEN EXPRESSION; ARTICLE; CHROMOSOME 21Q; CHROMOSOME 8Q; CHROMOSOME TRANSLOCATION 21; CHROMOSOME TRANSLOCATION 8; CLINICAL ARTICLE; CYTOGENETICS; FLOW CYTOMETRY; HUMAN; IMMUNOPHENOTYPING; LEUKOCYTE COUNT; PRIORITY JOURNAL; REMISSION; SURVIVAL;

EID: 0030838704     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.4.1643     Document Type: Article

References (34)

1. Hagemeijer A, Garson O, Kondo K: Translocation t(8;21) (q22;q22) in acute non-lymphocytic leukemia. Fourth International Workshop on Chromosomes in Leukemia, 1982. Cancer Genet Cytogenet 11:284, 1984
2. Berger R, Bernheim A, Ochoa-Noguera ME, Daniel M-T, Valensi F, Sigaux F, Flandrin G, Boiron M: Prognostic significance of chromosomal abnormalities in acute nonlymphocytic leukemia: A study of 343 patients. Cancer Genet Cytogenet 28:293, 1987
3. Samuels BL, Larson RA, LeBeau MM, Daly KM, Bitter MA, Vardiman JW, Barker CM, Rowley JD, Golomb HM: Specific chromosomal abnormalities in acute nonlymphocytic leukemia correlate with drug susceptibility in vivo. Leukemia 2:79, 1988
4. Keating MJ, Smith TL, Kantarjian H, Cork A, Walters R, Trujillo JM, McCredie KB, Gehan EA, Freireich EJ: Cytogenetic pattern in acute myelogenous leukemia: A major reproducible determinant of outcome. Leukemia 2:403, 1988
5. Fenaux P, Preudhomme C, Laï JL, Morel P, Beuscart R, Bauters F: Cytogenetics and their prognostic value in de novo acute myeloid leukemia: A report on 283 cases. Br J Haematol 73:61, 1989
6. Schiffer CA, Lee EJ, Tomiyasu T, Wiernik PH, Testa JR: Prognostic impact of cytogenetic abnormalities in patients with de novo acute nonlymphocytic leukemia. Blood 73:263, 1989
7. Dastugue N, Payen C, Lafage-Pochitaloff M, Bernard P, Leroux D, Huguet-Rigal F, Stoppa A-M, Marit G, Molina L, Michallet M, Maraninchi D, Attal M, Reiffers J: Prognostic significance of karyotype in de novo adult acute myeloid leukemia. Leukemia 9:1491, 1995
8. Bloomfield CD, Lawrence D, Arthur DC, Berg DT, Schiffer CA, Mayer RJ: Curative impact of intensification with high-dose cytarabine (HiDAC) in acute myeloid leukemia (AML) varies by cytogenetic group. Blood 84:111a, 1994 (abstr, suppl 1)
9. O'Brien S, Kantarjian HM, Keating M, Gagnon G, Cork A, Trujillo J, McCredie KB: Association of granulocytosis with poor prognosis in patients with acute myelogenous leukemia and translocation of chromosomes 8 and 21. J Clin Oncol 7:1081, 1989
10. Schoch C, Haase D, Haferlach T, Gudat H, Büchner T, Freund M, Link H, Lengfelder E, Wandt H, Sauerland MC, Löffler H, Fonatsch C: Fifty-one patients with acute myeloid leukemia and translocation t(8;21)(q22;q22): An additional deletion in 9q is an adverse prognostic factor. Leukemia 10:1288, 1996
11. Byrd JC, Weiss RB, Arthur DC, Shah D, Baer MR, Lawrence D, Davey F, Trikha ES, Carroll AJ, Tantravahi R, Qumsiyeh M, Patil SR, Moore J, Mayer RJ, Schiffer CA, Bloomfield CD: Extramedullary leukemia adversely affects hematologic complete remission rate and overall survival in patients with t(8;21)(q22;q22): Results from CALGB 8461. J Clin Oncol 15:466, 1997
12. Kita K, Nakase K, Miwa H, Masuya M, Nishii K, Morita N, Takakura N, Otsuji A, Shirakawa S, Ueda T, Nasu K, Kyo T, Dohy H, Kamada N: Phenotypical characteristics of acute myelocytic leukemia associated with the t(8;21)(q22;q22) chromosomal abnormality: Frequent expression of immature B-cell antigen CD19 together with stem cell antigen CD34. Blood 80:470, 1992
13. Hurwitz CA, Raimondi SC, Head D, Krance R, Mirro J, Kalwinsky DK, Ayers GD, Behm FG: Distinctive immunophenotypic features of t(8;21)(q22;q22) acute myeloblastic leukemia in children. Blood 80:3182, 1992
14. Porwit-MacDonald A, Janossy G, Ivory K, Swirsky D, Peters R, Wheatley K, Walker H, Turker A, Goldstone AH, Burnett A: Leukemia-associated changes identified by quantitative flow cytometry. IV. CD34 overexpression in acute myelogenous leukemia M2 with t(8;21). Blood 87:1162, 1996
15. Scott AA, Kopecky KJ, Grogan TM, Head DR, Troy FA, Mullen J, Ye J, Appelbaum FR, Theil KS, Willman CL: CD56: A determinant of extramedullary and central nervous system involvement in acute myeloid leukemia. Presented at United States and Canadian Academy of Pathology Meeting, San Francisco, 1994
16. Drach D, Zhao S, Drach J, Mahadevia R, Gattringer C, Huber H, Andreef M: Subpopulations of normal peripheral blood and bone marrow cells express a functional multidrug resistant phenotype. Blood 80:2729, 1992
17. Klimecki WT, Futscher BW, Grogan TM, Dalton WS: P-glycoprotein expression and function in circulating blood cells from normal volunteers. Blood 83:2451, 1994
18. Terstappen LWMM, Safford M, Könemann S, Loken MR, Zurlutter K, Büchner T, Hiddemann W, Wörmann B: Flow cytometric characterization of acute myeloid leukemia: II. Phenotypic heterogeneity at diagnosis. Leukemia 5:757, 1991
19. Reading CL, Estey EH, Huh YO, Claxton DF, Sanchez G, Terstappen LWMM, O'Brien MC, Baron S, Deisseroth AB: Expression of unusual immunophenotype combinations in acute myelogenous leukemia. Blood 81:3083, 1993
20. Stewart CC: Clinical applications of flow cytometry: Immunologic methods for measuring cell membrane and cytoplasmic antigens. Cancer 69:1543, 1992 (suppl 1)
21. Moore JO, Dodge RK, Amrein PC, Kolitz J, Lee EJ, Powell B, Godfrey S, Robert F, Schiffer CA: Granulocyte-colony stimulating factor (Filgrastim) accelerates granulocyte recovery after intensive postremission chemotherapy for acute myeloid leukemia with aziridinyl benzoquinone and mitoxantrone: Cancer and Leukemia Group B Study 9022. Blood 89:780, 1997
22. Stone RM, Berg DT, George SL, Dodge RK, Paciucci PA, Schulman P, Lee EJ, Moore JO, Powell BL, Schifter CA: Granulocyte-macrophage colony-stimulating factor after initial chemotherapy for elderly patients with primary acute myelogenous leukemia. N Engl J Med 332:1712, 1995
23. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C: Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group. Ann Intern Med 103:620, 1985
24. Mitelman F (ed): ISCN (1995): An International System for Human Cytogenetic Nomenclature. Basel, Switzerland, S Karger, 1995
25. Reidy MC, Muirhead KA, Jensen CP, Stewart CC: The use of a photolabeling technique to identify nonviahle cells in fixed homologous or heterologous cell populations. Cytometry 12:133, 1991
26. Clinical Applications of Flow Cytometry: Immunophenotyping of Leukemic Cells; Proposed Guidelines. Document H43-P. Villanova, PA, National Committee for Clinical Laboratory Standards, 1993
27. Cheson BD, Cassileth PA, Head DR, Schiffer CA, Bennett JM, Bloomfield CD, Brunning R, Gale RP, Grever MR, Keating MJ, Sawitsky A, Stass S, Weinstein H, Woods WG: Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia. J Clin Oncol 8:813, 1990
28. Seymour JF, Pierce SA, Kantarjian HM, Keating MJ, Estey EH: Investigation of karyotypic, morphologic and clinical features in patients with acute myeloid leukemia blast cells expressing the neural cell adhesion molecule (CD56). Leukemia 8:823, 1994
29. Bernheim A: Acute myelogenous leukemia with an 8; 21 translocation: A report on 148 cases from the Groupe Français de Cytogenetique Hematologique. Cancer Genet Cytogenet 44:169, 1990
30. Tallman MS, Hakimian D, Shaw JM, Lissner GS, Russell EJ, Variakojis D: Granulocytic sarcoma is associated with the 8;21 translocation in acute myeloid leukemia. J Clin Oncol 11:690, 1993
31. Byrd JC, Edenfield WJ, Shields DS, Dawson NA: Extramedullary myeloid cell tumors in acute nonlymphocytic leukemia: A clinical review. J Clin Oncol 13:1800, 1995
32. Lanier LL, Testi R, Bindl J, Phillips JH: Identity of Leu-19 (CD56) leukocyte differentiation antigen and neural cell adhesion molecule. J Exp Med 169:2233, 1989
33. Pearson L, Leith CP, Duncan MH, Chen I-M, McConnell T, Trinkaus K, Foucar K, Willman CL: Multidrug resistance-1 (MDR1) expression and functional dye/drug efflux is highly correlated with the t(8;21) chromosomal translocation in pediatric acute myeloid leukemia. Leukemia 10:1282, 1996
34. Baer MR, Stewart CC, Lawrence D, Powell BL, Schiffer CA, Davey FR, Arthur DC, Bloomfield CD: Multiparameter flow cytometry (MFC) analysis of de novo acute myeloid leukemia (AML) reveals low frequencies of lymphoid antigen expression and strong associations between immunophenotype and karyotype (CALGB 8361). Blood 86:266a, 1995 (abstr, suppl 1)